Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.77
0.06 (3.51%)
At close: Aug 15, 2025, 3:16 PM
Inhibikase Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 79.57K | 195.98K | 260.5K | 383.94K | 304.37K | 194.51K | 176.02K | 54.53K | 382.99K | 1.74M | 3.1M | 3.8M | 3.51M | 2.36M |
Cost of Revenue | 6.57K | 13.14K | 19.7K | 26.27K | 178.91K | 177.38K | 175.86K | 169.29K | 2.99M | 6M | 9.39M | 12.54M | 11.94M | 11.36M | 8.2M | 5.16M | 3.04M |
Gross Profit | -6.57K | -13.14K | -19.7K | 53.3K | 17.07K | 83.12K | 208.08K | 135.08K | -2.8M | -5.83M | -9.33M | -12.16M | -10.2M | -8.26M | -4.4M | -1.66M | -679.65K |
Operating Income | -38.4M | -28.59M | -20.06M | -19.01M | -20.16M | -20.09M | -20.02M | -19.77M | -18.2M | -18.13M | -18.84M | -18.79M | -16.78M | -14.77M | -10.93M | -7.12M | -4.9M |
Interest Income | 1.86M | 1.07M | 498.69K | 622.96K | 956.46K | 1.06M | 891.2K | 736.06K | 311.62K | 74.45K | 18.54K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -36.55M | -27.52M | -19.57M | -18.38M | -19.2M | -19.03M | -19.13M | -19.03M | -17.89M | -18.05M | -18.82M | -18.79M | -16.79M | -14.79M | -10.95M | -7.15M | -4.94M |
Net Income | -36.55M | -27.52M | -19.57M | -18.38M | -19.2M | -18.55M | -18.54M | -18.44M | -17.31M | -17.94M | -18.82M | -18.79M | -16.79M | -14.79M | -10.95M | -7.15M | -4.94M |
Selling & General & Admin | 14.6M | 11.37M | 7.03M | 7.02M | 6.82M | 6.73M | 6.68M | 6.59M | 6.47M | 6.22M | 6.53M | 6.63M | 6.58M | 6.51M | 6M | 4.93M | 3.7M |
Research & Development | 24.97M | 17.21M | 13.02M | 12.06M | 13.52M | 13.62M | 13.67M | 13.43M | 11.87M | 12.03M | 12.37M | 12.54M | 11.94M | 11.36M | 8.2M | 5.16M | 3.04M |
Other Expenses | -1.16M | n/a | n/a | n/a | n/a | -64.52K | -128.09K | -128.09K | -134.64K | -116.15K | -52.58K | -52.58K | -46.03K | n/a | 0.00 | 0.00 | 0.00 |
Operating Expenses | 38.4M | 28.58M | 20.05M | 18.99M | 20.14M | 20.08M | 20.02M | 19.77M | 18.2M | 18.13M | 18.84M | 18.79M | 16.78M | 14.77M | 10.93M | 7.12M | 4.9M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.00 | 163.00 | 320.00 | 8.13K | 19.92K | 26.9K | 33.64K | 33.77K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.48M | -1.48M | -1.48M |
Cost & Expenses | 38.4M | 28.59M | 20.06M | 19.01M | 20.16M | 20.09M | 20.02M | 19.77M | 18.2M | 18.13M | 18.84M | 18.79M | 16.78M | 14.77M | 10.93M | 7.12M | 4.9M |
Income Tax Expense | n/a | n/a | n/a | 46.17K | 83.29K | -391.05K | -502.89K | -549.06K | -586.18K | -111.83K | -314 | -314 | -314 | -314 | n/a | n/a | n/a |
Shares Outstanding (Basic) | 89.54M | 69.36M | 8.88M | 7.54M | 6.34M | 6.19M | 5.34M | 5.23M | 4.59M | 4.2M | 4.22M | 4.2M | 4.2M | 4.21M | 4.19M | 2.04M | 1.68M |
Shares Outstanding (Diluted) | 89.54M | 69.36M | 8.88M | 7.54M | 6.34M | 6.19M | 5.34M | 5.23M | 4.59M | 4.2M | 4.22M | 4.22M | 4.2M | 4.21M | 4.19M | 2.04M | 1.68M |
EPS (Basic) | -1.97 | -2.55 | -2.72 | -2.93 | -3.38 | -3.52 | -3.83 | -4.03 | -4.02 | -4.25 | -4.46 | -4.47 | -4.66 | -5.13 | -4.8 | -4.22 | -3.24 |
EPS (Diluted) | -1.97 | -2.55 | -2.72 | -2.93 | -3.38 | -3.52 | -3.83 | -4.03 | -4.02 | -4.25 | -4.46 | -4.47 | -4.66 | -5.13 | -4.8 | -4.22 | -3.24 |
EBITDA | -39.54M | -28.56M | -20.04M | -18.98M | -19.98M | -19.91M | -19.85M | -19.59M | -18.19M | -18.12M | -18.83M | -18.79M | -16.78M | -14.77M | -10.93M | -7.12M | -4.9M |
EBIT | -39.57M | -28.59M | -20.06M | -19.01M | -20.16M | -20.09M | -20.02M | -19.77M | -18.2M | -18.13M | -18.84M | -18.79M | -16.78M | -14.77M | -10.93M | -7.12M | -4.9M |
Depreciation & Amortization | 32.36K | 26.27K | 26.27K | 26.27K | 178.91K | 177.38K | 175.86K | 170.97K | 4.65M | 9.29M | 14.32M | 18.79M | 16.78M | 14.77M | 10.93M | 7.12M | 4.9M |